ANDREY, Dmytrenko

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

ANDREY, Dmytrenko
Centre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG]

Langue

Autre document

Ce document a été publié dans

2013-11-26

Résumé en anglais

A tangible compound repository is a very important source of exclusive organic molecules for screening projects in drug discovery. Tangible compounds denote molecules that are chemically feasible and having a high likelihood of being synthesized. Typically these are compounds that can be produced with synthetic schemes that have been validated. OTAVA Ltd. offers a collection of novel Tangible Screening Compounds including about 500,000 structures. The novel screening compounds ordered from this collection could be individually synthesized and delivered within 4 weeks. The compounds' purity is not less than 90% which can be validated by several methods: NMR and GC/LC/MS. NMR spectra are available upon request. Packaging of ordered compounds can be done in deep-well plates or bar-coded vials, weighing out is free. Tangible Screening Compounds from OTAVA is a unique opportunity to enrich your company's screening collection with molecules which are not available from other vendors. More information about OTAVA's novel screening compounds you can find at the web-site www.otavachemicals.com.< Réduire

Mots clés en anglais

Tangible Screening Compounds

drug discovery

organic molecules

Origine

Importé de hal

Unités de recherche

Centre d'Études Nucléaires de Bordeaux Gradignan (CENBG)